Avail Investment Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$471K Buy
1,302
+131
+11% +$44.8K 0.36% 67
2026
Q1
$412K Buy
+1,171
New +$417K 0.44% 55

Other funds holding AMGN

Avail Investment Partners's AMGN Position: Q2 2026 in Review

Avail Investment Partners increased its Amgen (AMGN) stake by 11% in Q2 2026, buying an estimated $44.8K and bringing the position to 1,302 shares worth $471K. The position accounts for 0.36% of the portfolio, ranked #67.

Avail Investment Partners first reported a position in AMGN in Q1 2026 and has held it in 2 quarters since. 3,134 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Avail Investment Partners held 1,302 shares of Amgen worth $471K as of Q2 2026.
  • Avail Investment Partners bought 131 Amgen shares in Q2 2026, an estimated $44.8K.
  • Amgen made up 0.36% of Avail Investment Partners's portfolio in Q2 2026, its #67 holding.
  • Avail Investment Partners first reported a position in Amgen in Q1 2026 and has held it in 2 quarters since.
  • 3,134 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Avail Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.